chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Migraine, Rash
Clinical narrative: Information has been received from a certified medical assistant concerning a 26 year old female patient with penicillin, amoxicillin allergy and (PERCOCET) allergy who on 27-MAR-2009 was vaccinated with a dose of GARDASIL (lot# 659655/0940X). On 28-MAR-2009 the patient experienced a rash on both her arms lasting about 24 hours after vaccination with GARDASIL. She also experienced dizziness and migraines that lasted for a few weeks after vaccination. The patient sought medical attention via telephone call. Additional information has been requested.
Age: 24.0
Sex: F
Vaccine: HPV4
Symptoms: Nausea, Pregnancy test, Smear cervix
Clinical narrative: Information has been received from a 24 year old female with no pertinent medical history and no drug reactions/allergies who on 11-June-2009 was vaccinated with the first dose of GARDAISL. No concomitant therapies were included. The patient reported that she has nausea since 12-June-2008. The patient sought medical attention. A pap smear and a pregnancy test were done (resulted not provided). At the time of the reporting, the patient had not recovered. On follow-up information that patient wanted to know how long the nausea lasted in the clinical studio. No further information is available.
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Inappropriate schedule of drug administration, Syncope
Clinical narrative: Information has been received from a health professional concerning a 11 year old female patient who on 23-APR-2008 was vaccinated IM with the first dose of GARDASIL. On approximately 12-JUN-2009, 14 months after the first dose, the patient was vaccinated IM with the second dose of GARDASIL (lot# 661766/0652X). After received her second dose of GARDASIL, the patient experienced faint. The patient had recovered. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Alopecia
Clinical narrative: Information has been received from a nurse practitioner concerning a 22 year old female with no drug reactions or allergies who on 22-May-2009 was vaccinated with the second dose of GARDASIL. Concomitant therapy included ZYRTEC, DETROL, FLONASE and hormonal contraceptives (Unspecified). Subsequently on an unspecified date the patient experienced a bald spot. The patient did not seek medical attention. At the time of this report, the patient had not recovered. This is one of several reports received from the same source. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Smear cervix abnormal
Clinical narrative: Information has been received from a physician concerning an "around 12 year old" female with unknown allergies and unknown medical history who on an unspecified date was vaccinated with a dose of GARDASIL (dose number, vaccination date not reported). Subsequently, on an unspecified date after vaccination the patient had a positive papsmear test. Unspecified medical attention was sought. At the time of report, the patient's status was unknown. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a physician concerning a female patient who about a week and a half ago approximately June 2009, was vaccinated with a dose of GARDASIL, MENACTRA and another vaccine (name and manufacturer unspecified) the patient went out in the parking and fainted. The physician reported that the patient's mother called the paramedics and then the patent was taken inside the office was monitored and then was able to leave the physician's office. The patient had recovered on the same day she received vaccine. The physician did not mention what the paramedics did when the patient was in the office parking lot. No further information is available.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Biopsy, Muscle injury, Rash
Clinical narrative: Information has been received from a physician and company representatives concerning a 14 year old female who in approximately August 2008, was vaccinated with the 3rd of GARDASIL. Lot number was not available. In September 2008, approximately 1 month after receiving the 3rd dose the patient subsequently developed a rash, and she also developed muscle damage. At the time of report she was getting unspecified tests including a biopsy in the hospital but it was unknown if she was admitted to the hospital. She was currently under observation. She had not recovered at the time of report. Additional information is not expected.
Sex: F
Vaccine: HPV4
Symptoms: Injection site swelling
Clinical narrative: Information has been received from a physician concerning a female who was vaccinated with her second dose of GARDASIL (site and route of administration not reported). About two weeks post vaccination the patient experienced swelling at the injection site. The patient's swelling at the injection site persisted. No problem with the initial dose. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Lyme disease
Clinical narrative: Information has been sent from a consumer concerning her daughter who on unspecified date was vaccinated with the second dose of GARDASIL (lot number, route and site not reported). It was reported that the patient was only able to receive two out of the three GARDASIL vaccinations. After the second vaccine she was diagnosed with Lyme's disease and was told that it was not good idea to give her any type of vaccination with an immune type disease such as Lyme. Therapy with human papilomavirus vaccine was discontinued. At the time of reporting the patient's outcome was unknown. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Adverse event
Clinical narrative: Information has bee received from a physician concerning a female who was vaccinated with a dose of GARDASIL. Subsequently the patient was taken to an emergency room. The reason the patient was taken to the emergency room was unspecified. At the time the outcome was unknown. This is one of several reports receiving from the same source. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Alopecia
Clinical narrative: Information has been received from a nurse practitioner concerning a female who was vaccinated with GARDASIL. Subsequently the patient went completely bald after getting GARDASIL. The patient's outcome was unknown. This is one of several report's received from the same source. Attempts are being made to verify the existence of an identifiable patient.
Sex: F
Vaccine: HPV4
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning a female who was vaccinated with the first dose of GARDASIL.  The patient developed rash on her back a few days after receiving GARDASIL.  The patient sought medical attention at the office.  The outcome of the event was unknown.  No further information is available.
Age: 21.0
Sex: F
Vaccine: HPV4
Symptoms: Menstrual disorder, Metrorrhagia
Clinical narrative: Information has been received from a 21 year old female with no medical history who about 2 months ago in approximately April 2009, was vaccinated with her 1st dose of GARDASIL. Concomitant medication included hormonal contraceptives (unspecified). There were no labs and diagnostic tests performed. Subsequently the patient was spotting and her menstrual cycle was changing after getting GARDASIL. The patient hadn't sought medical attention. At the time of report the patient hadn't recovered. No further information is available.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Nausea, Pyrexia
Clinical narrative: Information has been received from a licensed practical nurse concerning a 13 year old female who on 03-AUG-2007 was vaccinated with a dose of GARDASIL (lot # 653735/0688F). On 04-AUG-2007 the patient developed nausea and fever. The patient sought unspecified medical attention. The patient recovered from nausea and fever on an unspecified date. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Injection site pain, Injection site swelling, Urticaria
Clinical narrative: Information has been received from a consumer concerning a 15 year old female who on 13-JUN-2009 was vaccinated with the first dose of GARDASIL 0.5mL into the left arm. On 14-JUN-2009, the patient experienced pain, swelling and soreness at the injection site after getting the first dose of GARDASIL. Currently the patient developed hives on her left arm where the shot was given. At the time of the report the patient had not recovered. The patient sought unspecified medical attention. No further information is available.
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a physician concerning a female patient who on a unspecified date was vaccinated with a dose of GARDASIL (lot not reported) (the reporter was unsure of which dose this was in the series) and then the patient fainted. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Loss of consciousness, Presyncope
Clinical narrative: Information has been received from a nurse practitioner concerning a 22 year old female with a history of vasovagal responses, but not as a reaction to medications or vaccines who on 16-JUN-2009 was vaccinated with a 0.5 mL first dose of GARDASIL, intramuscularly. The patient had a vasovagal response after getting GARDASIL and she passed out cold. No laboratories studies performed. The patient sought unspecified medical attention. The patient recovered on 15-JUN-2009 after stopping therapy. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Nausea
Clinical narrative: Information has been received from the mother of the patient concerning a 14 year old female who on an unspecified day in February 2007 was vaccinated with the first dose, on an unspecified date the patient received her second dose and approximately in August 2007 third dose of GARDASIL (routes and lot numbers unspecified). Concomitant vaccine therapy included a dose of MENACTRA (dose, route and lot number not reported). The parent reported "the patient began experiencing chronic nausea 2 months after receiving her third dose of GARDASIL (October 2007). The patient went to the emergency room but was not admitted to the hospital (date unspecified). The patient started taking unspecified medication for chronic nausea. At the time of the report the outcome of the patient was recovered. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a physician concerning a 14 year old female patient who on an unknown date was vaccinated with the second dose of GARDASIL.  It was reported that after getting the second dose of GARDASIL the patient fainted.  It was reported that there was no information about the first dose of GARDASIL.  The patient sought unspecified medical attention.  On an unknown date, the patient recovered.  Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a nurse practitioner concerning a 17 year old female patient with a broken toe who on 17-JUN-2009 was vaccinated IM with the first 0.5 mL dose of GARDASIL. On 17-JUN-2009 the patient fainted after receiving GARDASIL. The patient sought unspecified medical attention. A couple of minutes later the patient recovered. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Condition aggravated, Loss of consciousness, Musculoskeletal stiffness
Clinical narrative: Information has been received from a nurse concerning a 17 year old female patient who "has a history of passing out, even if you just draw blood". On 17-JUN-2009 the patient was vaccinated with a first dose of GARDASIL (lot # not reported) 0.5ml, intramuscularly. After got the vaccine on 17-JUN-2009 "the patient passed out and got stiff". On 17-JUN-2009 the patient recovered. The patient sought unspecified medical attention. There were no laboratories diagnostics studies performed. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Papilloma viral infection, Smear cervix
Clinical narrative: Information has been received from a physician concerning a female with unknown medical history and unknown drug allergies who received all three doses of GARDASIL. Subsequently the patient presented with a high risk HPV. A PAP test was performed. The patient's outcome was not reported. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Asthenia, Blood pressure increased, Blood test, Burning sensation, Dysgeusia
Clinical narrative: Information has been received from a registered nurse concerning a 22 years old female with unknown medical history and unknown drug allergies who on 16-JUN-2009 was vaccinated with the first dose of GARDASIL at 4:00pm.  Concomitant therapy included MUCINEX.  "Starting at 10:30pm the patient started having episodes of weakness, burning, tingling pain and a metallic taste from her tongue to her toes."  "She had these episodes 15-20 times before going to the hospital."  At 12:23am on 17-JUN-2009 the patient went to the ER Room but was not admitted.  She underwent unspecified blood work (results not reported).  She was released at 3:45am that same day.  When the patient got vaccinated her blood pressure was 125/72.  At the hospital it was 156/94.  The patient had recovered on 17-JUN-2009.  Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Pain, Paraesthesia
Clinical narrative: Information has been received from a registered nurse concerning a 22 years old female with unknown medical history and unknown drug allergies who on 16-JUN-2009 was vaccinated with the first dose of GARDASIL at 4:00pm.  Concomitant therapy included MUCINEX.  "Starting at 10:30pm the patient started having episodes of weakness, burning, tingling pain and a metallic taste from her tongue to her toes."  "She had these episodes 15-20 times before going to the hospital."  At 12:23am on 17-JUN-2009 the patient went to the ER Room but was not admitted.  She underwent unspecified blood work (results not reported).  She was released at 3:45am that same day.  When the patient got vaccinated her blood pressure was 125/72.  At the hospital it was 156/94.  The patient had recovered on 17-JUN-2009.  Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Cervical dysplasia, Genital herpes, Papilloma viral infection, Smear cervix abnormal
Clinical narrative: Information has been received from a physician assistant concerning a female patient who on unspecified dates was vaccinated with all three 0.5 ml doses of GARDASIL. At the time of vaccination the patient was not yet sexually active. Subsequently, after all 3 doses of GARDASIL the patient became sexually active and developed genital herpes. Unspecified medical attention was sought. It was noted that after the treatment the patient had two Papanicolaou (PAP) tests done. The first test came back atypical squamous cells of undetermined significance (ASCUS) and the second test came back high risk human papilloma viral (HPV). At the time of the report, the patient's status was unknown. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a physician concerning a female patient who was vaccinated with a dose of GARDASIL. Subsequently the patient fainted after receiving the GARDASIL. The patient had recovered (date unspecified). The patient had sought the physician for medical attention. This is one of several reports received from the same source. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning a female patient who in September 2008 and November 2009 was vaccinated with the first and second dose of GARDASIL. On 02-APR-2009 the patient was vaccinated with the third dose of GARDASIL IM 0.5ml. "A week and a half ago" on approximately 07-JUN-2009 the patient developed "a rash on her arms and legs". "The patient's other doctor" said that it was due to GARDASIL. Unspecified medical attention had been sought. No further information is available.
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a nurse practitioner concerning a female patient who was vaccinated with GARDASIL. Subsequently the patient fainted. The patient had sought the nurse practitioner for medical attention and recovered (date unspecified). Additional information has been requested.
Age: 32.0
Sex: F
Vaccine: HPV4
Symptoms: Pain, Rash pruritic
Clinical narrative: Information has been received from a 32 year old female consumer with sulfa and shellfish allergies and a history of endometriosis who on 16-JUN-2009 was vaccinated with the first 0.5ml dose of GARDASIL. Concomitant therapy included NORTREL. On 19-JUN-2009, the patient developed a painful, itchy rash on her arms, legs, chest and abdomen. Medical attention was sought by a phone call. There were no lab studies performed. The patient reported that she was now taking BENADRYL and the rash was improving. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: HPV4
Symptoms: Dyspnoea, Headache, Nausea, Pyrexia, Swelling
Clinical narrative: Information has been received from a nurse concerning a 19 year old female with a history of a "severe reaction to an unspecified meningitis vaccine" and no pertinent medical history who on 12-JUN-2009 was vaccinated with the first dose of GARDASIL (IM, lot number  658271/0558X).  There was no concomitant medication.  The patient experienced a fever, swelling and nausea on 18-JUN-2009, several days after the vaccination.  Unspecified medical attention was sought.  No lab/diagnostic studies were performed.  It was noted that the patient recovered 2 days after onset of symptoms, on 20-JUN-2009.  Follow-up information received from the nurse on 22-JUN-2009.  At that time the patient continued to experience headaches but her fever resolved on 19-JUN-2009.  The patient was experiencing trouble breathing.  The patient took two doses of BENADRYL and breathing improved.   The patient will not administered her second and third dose of GARDASIL.  Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Alopecia
Clinical narrative: Information has been received from a certified nurse practitioner concerning a 22 year old female with overactive bladder and allergies and no illness at the time of vaccination , who on 20-Mar-2009 and 22-May-2009 was vaccinated into the left deltoid with first dose (lot number reported as 13124, not valid) and second dose (lot number reported as U5581, not valid) respectively of GARDASIL. Concomitant therapy included FLONASE, ZYRTEC, birth control pills and DETROL LA. Four days after vaccination on 26-May-2009, the patient had a bald spot on head, she denied change in any medications. It was reported that nothing else was different. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a physician concerning a female patient who was vaccinated with a dose of GARDASIL. Subsequently the patient fainted after receiving the GARDASIL. The patient had recovered (date unspecified). The patient sought the physician for medical attention. This is one of several reports received from the same source. Additional information has been requested.
Age: 25.0
Sex: F
Vaccine: HPV4
Symptoms: Bronchitis, Dyspnoea, Pain, Pyrexia
Clinical narrative: Information has been received from a nurse concerning a 25 year old with a history of asthma female who on 18-JUN-2009 was vaccinated intramuscularly with the first 0.5mL dose of GARDASIL (LOT# 661531/1311X). On 19-JUN-2009, after receiving the dose, the patient developed shortness of breath, achiness and a fever of 101 F degree. The patient was treated in an emergency room. She was diagnosed with possible asthma or bronchitis or a reaction to the GARDASIL vaccination and treated with prednisone and ZITHROMAX. On 22-JUN-2009, the nurse spoke with the patient, and was told the patient was still achy, but was feeling better. Additional information has been requested.
Age: 13.0
Sex: F
Vaccine: HPV4, PPV
Symptoms: Myalgia, Pain
Clinical narrative: Information has been received from a physician concerning a 13 year old female who at time of vaccination with unspecified sickness was vaccinated with a dose of GARDASIL (LOT# not reported, duration and dose not reported). Secondary suspect vaccination included PNEUMOVAX 23 (duration and dose not reported) and another unspecified vaccine. It was reported that the patient was "already sick" at the time of vaccination and went to the office for a check up and was administered the vaccinations. After receiving vaccinations, the patient experienced muscle achiness and soreness. At the time of the report it was reported that the patient was recovering. No further adverse event information provided at this time of report. No further information is available.
Sex: F
Vaccine: HPV4
Symptoms: Hypoaesthesia, Inappropriate schedule of drug administration, Paraesthesia
Clinical narrative: Information has been received from a pharmacy technician concerning a female with a history of premature who in January 2009, was inadvertently vaccinated with the fourth dose of GARDASIL (LOT# not reported). After vaccination, the patient experienced numbness and tingling sensations on her arm. The patient had one dose from the patient's Gynecologist and received two doses from the patient's pediatrician. The patient sought unspecified medical attention and the outcome was unknown. No further information is available at this time of report. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Human papilloma virus test positive, Smear cervix abnormal
Clinical narrative: Information has been received from a consumer concerning his 22-year-old daughter who was vaccinated with all three doses of GARDASIL (dose, route and lot number not reported) and the last dose was received in July 2007. There were no concomitant medications. Last week (on approximately 15-JUN-2009) the patient had a PAP test done and it came back positive for HPV (unspecified which type). The patient had sought unspecified medical attention. At the time of the report, the patient's status was not recovered. No further information is available.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Alopecia
Clinical narrative: Information has been received from a consumer concerning her 16-year-old daughter with no medical history nor drug reactions/allergies who was vaccinated with the last dose of GARDASIL in April 2009, the reporter was not sure when the first dose was given but stated that the doses of GARDASIL were given "on time". There were no concomitant medications. After receiving the third dose of GARDASIL the patient's hair has been "falling out in clumps". The patient had not sought medical attention. At the time of the report, the patient's status was not recovered. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a consumer concerning her daughter who on 22-JUN-2009 was vaccinated with the first dose of GARDASIL. On 22-JUN-2009 the patient fainted shortly after she took her first GARDASIL. The patient's outcome was unknown. No further information is available.
Sex: F
Vaccine: HPV4
Symptoms: Activities of daily living impaired, Headache
Clinical narrative: It was reported in an internet article, concerning a female who was vaccinated with GARDASIL (date, dose, route not reported).  The author of the article reported that "one girl who said she has suffered a headache non stop for 3 weeks now and it is destroying her quality of life.  This is one of several reports received from the same source.  No further information is available.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Ear infection
Clinical narrative: Information has been received from a consumer concerning her daughter, a 15 year old female who on 04-APR-2009 was vaccinated with the first dose of GARDASIL. The mother's patient stated that her daughter was suppose to receive the second dose of GARDASIL on 06-JUN-2009, because she had an ear infection. The outcome of the event was unknown. The patient sought unspecified medical attention. No further information is available.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a registered pharmacist concerning a 17 year old female patient who on an unspecified date had been vaccinated with MENACTRA, prior to the first dose of GARDASIL (lot # not reported), IM route, that was administered on 17-JUN-2008. On an unspecified date, the patient returned to the office for her second dose of GARDASIL but was inadvertently given MENACTRA instead. The pharmacist mentioned that the lot number that was documented in her records correlated with MENACTRA. It began with an "M". The pharmacist was aware that the GARDASIL lot numbers are 4 numbers followed by an alpha and this was not how the dose was documented. On 30-DEC-2008, the patient returned to the office and received a third vaccination that was GARDASIL (lot # not reported), IM route. The pharmacist mentioned that the lot number patterns for the first and the third doses match the GARDASIL standard. No adverse effects were reported. Additional information has been requested.
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness
Clinical narrative: Information has been received from a registered nurse concerning a 26 year old female with penicillin allergy and sulfonamide allergy and a history of fainting after getting her ears pierced who on 23-JUN-2009 was vaccinated IM with the first 0.5 mL dose of GARDASIL (lot # 658271/0558X). There was no concomitant medication. The patient felt light-headed a few minutes after receiving her first dose of GARDASIL. The patient rested and was monitored in the office. She subsequently recovered fully. Additional information is not expected.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Colposcopy, Inappropriate schedule of drug administration, Smear cervix abnormal
Clinical narrative: Information has been received from a health professional concerning an 18 year old female with prophylaxis who on 15-NOV-2006 was vaccinated with the first dose of GARDASIL (lot # 653978/0955F) 0.5 mL, I.M. route, on 17-JAN-2007 was vaccinated with the second dose of GARDASIL (lot # 655617/1447F) 0.5 mL, I.M. route, on 23-MAY-2007 was vaccinated with the third dose of GARDASIL (lot # 657736/0389U) 0.5 mL, I.M. route. Concomitant therapy included DESOGEN. The patient received a second series of GARDASIL. On 27-OCT-2008, was vaccinated with the first dose of the second series of GARDASIL (lot # 660616/0570X) 0.5 mL, I.M. route and had a PAP test abnormal. On 20-NOV-2008, the patient had a colposcopy (results not reported). On 17-FEB-2009, was vaccinated with the second dose of the second series of GARDASIL (lot # 661531/1311X) 0.5 mL, I.M. route. On 15-JUN-2009, was vaccinated with the third dose of the second series of GARDASIL (lot #660616/0570X) 0.5 mL, I.M. route and had a PAP test abnormal. At the time of the report the outcome of the event was unknown. The patient sought unspecified medical attention.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a registered nurse concerning a 13 year old female who on an unspecified date was vaccinated with second dose of GARDASIL (dose, route and lot number not reported). It was reported that "a few minutes after receiving the second dose", the patient experience a syncope. The patient recovered "within 30 minutes to 1 hour". The patient sought medical attention by contacting the physician. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Blister
Clinical narrative: Information has been received from a certified nurse midwife concerning a female patient with sulfonamide allergy who on an unknown date was vaccinated with the first dose of GARDASIL. It was reported that after the patient received the GARDASIL, she developed water blisters on her finger tips. The patient called the office in order to seek medical attention. At the time of reporting the patient had recovered. Additional information has been requested.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Diarrhoea, Headache, Nausea, Vomiting
Clinical narrative: Information has been received from a Registered Nurse concerning a 16 year old female patient who on 23-MAR-2009 was vaccinated with a first dose of GARDASIL (lot# 0702X).  On 28-MAY-2009 she received second dose of GARDASIL (lot # not reported).  On 16-JUN-2009 she began experiencing a headache, nausea, vomiting and diarrhea.  The patient sought unspecified medical attention.  The patient's outcome was not reported.  Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Adverse event
Clinical narrative: Information has been received from a physician's assistant who reported that a patient came into the office and reported that a friend of hers, who was vaccinated with GARDASIL had an adverse event (not further specified, no details reported) and was hospitalized. At the time of reporting the patient's outcome was unknown. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Impaired healing, Skin lesion
Clinical narrative: Information has been received from a consumer mother concerning her daughter with no pertinent medical history and no known drug allergies who in 2008 was vaccinated with the third dose of GARDASIL (lot# not provided). There was no concomitant medication. Mother stated that she noticed after her daughter's third dose of GARDASIL, her daughter's cuts would bubble up when healing. The scars were more like lesions a quarter inch thick raised off the skin. Patient sought unspecified medical attention. No lab/diagnostic studies performed. At the time of this report patient had not yet recovered. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: HPV4, MMR, MNQ, VARCEL
Symptoms: Eye pain, Intraocular pressure increased, Myodesopsia, Photophobia, Retinal disorder
Clinical narrative: Information has been received from a license practical nurse concerning her 19 year old daughter with no pertinent medical history who on 20-JAN-2009 was vaccinated with the third dose of GARDASIL (lot# 661531/1311X).  Other suspect vaccines received on that same date included: MMRII (lot# 656034/0182U), VARIVAX (Merck) (lot# 659845/0270X) and MENACTRA.  Subsequently, on the same day the patient developed vision problems.  Few days later she complained of pain in her right eye.  She saw many "floaters" in her field of vision.  Patient sought medical attention.  She went to see an ophthalmologist and tested normal.  Then she became sensitive to the outdoor and indoor lights.  She saw a specialist and he determined that she had "inflamed retinal bilateral".  She was given steroids into her eye but the pressure still increased.  She then saw another  doctor who determined that she had massive pressure in her right eye with "rainbow vision" and performed a surgery on her right eye on 23-JUN-2009 in an outpatient clinic.  At the time of this report the patient was in post surgical treatments, recovering.  Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: HPV4, MMR, MNQ, VARCEL
Symptoms: Surgery, Visual impairment
Clinical narrative: Information has been received from a license practical nurse concerning her 19 year old daughter with no pertinent medical history who on 20-JAN-2009 was vaccinated with the third dose of GARDASIL (lot# 661531/1311X).  Other suspect vaccines received on that same date included: MMRII (lot# 656034/0182U), VARIVAX (Merck) (lot# 659845/0270X) and MENACTRA.  Subsequently, on the same day the patient developed vision problems.  Few days later she complained of pain in her right eye.  She saw many "floaters" in her field of vision.  Patient sought medical attention.  She went to see an ophthalmologist and tested normal.  Then she became sensitive to the outdoor and indoor lights.  She saw a specialist and he determined that she had "inflamed retinal bilateral".  She was given steroids into her eye but the pressure still increased.  She then saw another  doctor who determined that she had massive pressure in her right eye with "rainbow vision" and performed a surgery on her right eye on 23-JUN-2009 in an outpatient clinic.  At the time of this report the patient was in post surgical treatments, recovering.  Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Discomfort
Clinical narrative: Information has been received from a nurse practitioner concerning a female patient who on an unspecified date was vaccinated with GARDASIL (lot # not reported), 0.5 mL, IM administration. The nurse stated that the patient was feeling uncomfortable after getting the GARDASIL, and she came back to the physician's office. The patient laid down and she later felt fine. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a physician concerning a 12 year old female who on 24-JUN-2009 was vaccinated intramuscularly with the 0.5 ml first dose of GARDASIL (lot no. not reported). There was no concomitant medication. The physician reported that on 24-JUN-2009 the patient was still on the examination table when she experienced syncope. The patient was laid down on the table and recovered in seconds. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Pyrexia
Clinical narrative: Information has bee received from a consumer concerning a female patient who on an unspecified date was vaccinated with a dose of GARDASIL (dose, route and lot number not reported). Subsequently, the patient developed fever for a couple of days. It was not specified if the patient sought medical attention.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Injection site reaction
Clinical narrative: Information has been received from a physician concerning a 17 year old female who on an unspecified date was vaccinated with a dose of GARDASIL. The physician reported that "a couple of months ago", the patient experienced injection site reaction. The patient sought unspecified medical attention. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Colposcopy, Human papilloma virus test positive
Clinical narrative: Information has been received from a registered nurse concerning 3 female patient who were vaccinated with a 0.5 mL third dose of GARDASIL, intramuscularly. The patients tested positive for HPV later. The patients had a colposcopy. The patients sought unspecified medical attention. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Alopecia
Clinical narrative: Information has been received from a licensed practical nurse concerning her daughter with no medical history of allergies, who in October 2008, was vaccinated with first and only dose of GARDASIL, intramuscularly. There was no concomitant medication. The patient had been experiencing hair loss after receiving the GARDASIL vaccine dose. The reporter even noted a bald spot on patients head. No laboratories studies performed. The patient sought unspecified medical attention. At the time of this report the patient had not recovered. Additional information has been requested. 11/9/2009 PCP records for 2 visits 9/2009. Patient with c/o's hair loss, fungus on toenails, sore on foot. Impression: onychomycosis
Age: 9.0
Sex: F
Vaccine: HPV4
Symptoms: Eye swelling, Face oedema, Lip swelling
Clinical narrative: Information has been received from a Physician Assistant concerning a 9 years old female who on 22-JUN-2009 was vaccinated with the first 0.5mL dose of GARDASIL (lot# not provided). There was no concomitant medication. On 23-JUN-2009 the patient developed facial edema like eyes, face and lips were swollen after getting the first dose of GARDASIL. Unspecified medical attention was sought. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Electrocardiogram normal
Clinical narrative: Information has been received from a nurse practitioner concerning her 15 year old daughter who was administered all three dose of GARDASIL, and third dose was given in "October/November 2008" timeframe. It was reported that from last two months, the patient was experiencing dizziness and felt like fainting. There was an ECG test and results came normal. At the time of reporting, the patient had not recovered. The patient sought unspecified medical attention. Additional information has been requested.  8/3/09 Cardiology consultant records received DOS 7/16/09 Assessment: Neurocardiogen instability/vasovagal syncope. Patient c/o episodes of lightheadedness followed by blackness of her vision. Denies true syncopal episodes. Denies any other symptoms referable to the cardiovascular system.  ICD-9 Codes: Light-headedness - 780.4   Syncope and collapse - 780.2   8/6/09 PCP medical records DOS 12/9/08 to 6/8/09. Assessment: Blacking out - unknown etiology. Sore throat, lump on right side of neck. Felt warm. Throat red. Rash on stomach, erythematous and scaly - tinea. Nose bleeds, dizzy spells, blacked out, head and eyes throb. For 2-3 minutes cannot hear or see. Birth control implant. 'Bug bite' on knees and foot, itch, hurt, swelling - local reaction. Rash on abdomen, arm, leg - contact dermatitis.  8/14/09 Neuro consult rec'd dated 6/30/09.  Pt presented with c/o 1 month hx of headaches rated 10/10 on pain scale.  Sometimes associated with nausea, blurry vision, seeing spots, photo/sonophobia. Also c/o intermittent lightheadedness and near syncopal episodes x 1 yr. Also dx with Bipolar d/o around that time, currently depressed.  PE (+) for brisk refelexes.  assessment:  Migraine variant.  Bipolar D/O, symptomatic.
Age: 12.0
Sex: F
Vaccine: HPV4
Symptoms: No reaction on previous exposure to drug, Pruritus generalised, Rash
Clinical narrative: Information has been received from a nurse practitioner student concerning a 12 year old female with allergy to ROCEPHIN and no past medical history who on 02-APR-2009 was vaccinated with the first dose of GARDASIL (lot# 659180/1758U). The patient received her second dose of GARDASIL on 23-JUN-2009. There was no concomitant medication. It was reported that after second vaccination, the patient developed a rash over her face and itching over her body. The patient was treated with BENADRYL and ZYRTEC. The patient sought medical attention as the nurse spoke to patient's mother. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: HPV4
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning a 23 year old female with no known pertinent medical history, who on 19-JUN-2009 was vaccinated with the first dose of GARDASIL.  Lot No was not provided.  The physician reported that on 19-JUN-2009, the patient developed upper body rash after getting the first dose of GARDASIL.  On 23-JAN-2009, the patient recovered.  No laboratories diagnostic studies were performed.  The patient sought medical attention.  Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: HPV4
Symptoms: Papilloma viral infection
Clinical narrative: Information has been received from a nurse concerning a 19 year old female who received all 3 doses of GARDASIL (on 27-DEC-2006 was vaccinated with the first dose, on 05-MAR-2007 with the second dose and on 12-JUL-2007 with the third dose) and at an annual check up at obstetrician's office, she tested positive for an HPV infection.  It was unknown if the patient sought medical attention.  Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Gaze palsy, Loss of consciousness, Syncope
Clinical narrative: Information has been received from a office assistant concerning a 14 year old female with unspecified drug reactions/allergies and medical history, who on unspecified date in August 2008 and on 21-Oct-2008 received first and second doses respectively of GARDASIL (lot number for the second dose: 661044/0548X, route not reported). There was unspecified concomitant medication. The office assistant reported the patient was given the first dose of the vaccine and 5 minutes later the patient "passed out" on an unspecified date in August 2008. Also the office assistant stated the second time, the patient was given the vaccine, syncopal episode was more severe and more "seizure like" and the "patient's eyes rolled back" (approximately 21-Oct-2008). On an unspecified date the patient was recovered from this, but was not given the third dose. The patient sought medical attention by consulted physician. Follow up information has been received from the office assistant who reported the patient with no known allergies with attention deficit / hyperactivity disorder and she took STRATTERA 26mg each morning. On 01-Aug-2008, the only vaccine was the first dose of GARDASIL and that was the only vaccine received that day. Five minutes after injection, the patient passed out at the reception desk and she did not need treatment and recovered quickly. On 21-Oct-2008, the only vaccine administered was the second dose of the GARDASIL vaccine and  on that date the reaction was worse, with "eyes rolling back". The patient did not lose consciousness and the physician was able to speak with her during the event. The office assistant said the physician was able to speak with her during the event. The office assistant said the physician used the term "seizure like", but in fact the patient did not have a seizure. Again no treatment was necessary. No labs / diagnostic were performed. The patient did not need to go to the ER. And the patient will be not receiving the third dose.  No further information is available.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Abasia, Blood test, Syncope
Clinical narrative: Information has been received from a physician concerning a 22 year old female who "four months ago" in approximately February 2009, was vaccinated with the first dose of GARDASIL and two months after the first dose, "two months ago" in approximately, April 2008, the patient was vaccinated with the second dose of GARDASIL. The physicist stated that he gave the first dose of GARDASIL and twelve hours later the patient's boyfriend called the doctor and stated that the patient fainted and then could not walk. The doctor sent the patient to the emergency room. A full workup was done. The patient was fine. There was no problems. The patient was not on birth control pills and she was not pregnant. The patient is fine now. Additional information has been requested.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Blister
Clinical narrative: Information has been received from a nurse concerning a 21 year old female who on 11-MAY-2009 was vaccinated with the first dose of GARDASIL (LOT# 661952/1129X). Concomitant therapy included NUVARING and MACROBID. On an unspecified date, after vaccination, the patient experienced blisters in her fingers and toes. The patient sought medical attention and spoke with a nurse. The patient's outcome was not reported. No other information was provided at the time of report. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: HPV4
Symptoms: Urticaria
Clinical narrative: Information has been received from a physician concerning an 11 year old female who on 18-JUN-2009 was vaccinated with the first dose of GARDASIL (lot# 661953/1130X, route and site of administration not reported). Concomitant therapy included MENACTRA. On 23-JUN-2009 the patient came back in the office and presented her skin. The patient was diagnosed of urticaria all over her trunk and her leg in the thigh area. At the time of reporting the patient's outcome was unknown. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Syncope
Clinical narrative: Information has been received from a nurse concerning a female who on an unspecified date was vaccinated intramuscularly with a 0.5mL dose of GARDASIL (LOT# not reported). On an unspecified date, after vaccination, the patients experienced "2 episodes of syncope and dizziness"> The patient was sought unspecified medical attention and no outcome was provided. No further information is available.
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a physician concerning a female who was vaccinated IM, 0.5 ml, with a dose of GARDASIL and then fainted. The patient sought unspecified medical attention. There were no laboratory studies performed. The patient had recovered immediately afterwards. Additional information has been requested.
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Asthenia, Fatigue, Mental impairment
Clinical narrative: Information has been received from a registered nurse concerning a 26 year old female who on 25-JUN-2009 was vaccinated with the first dose of GARDASIL (lot# 662518/0087Y, 0.5ml, route and site of administration not reported). Concomitant therapy included (ZOLOFT), amphetamine (ADDERALL TABLETS), (XANAX), (AMBIEN), (CLEOCIN) and (NUVARING). The patient's relevant medical history and past drug history were unknown. On 25-JUN-2009 the patient reported feeling weak, tired and mentally slow. As of 25-JUN-2009 the patient was still feeling weak, tired and mentally slow. It was unknown if the patient would continue to take the GARDASIL vaccine. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Colposcopy, Smear cervix abnormal
Clinical narrative: Information has been received from a nurse concerning a 22 year old female who in April 2009, was vaccinated with her first dose of GARDASIL injection. In May 2009, the patient went to have her yearly Pap test done and her pap came back to the office today on 25-JUN-2009 to have a "colposcopy" done, and those results were not yet available. The patient's outcome was unknown. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HEPA, HPV4, VARCEL
Symptoms: Dyskinesia, Syncope
Clinical narrative: Information has been received from a medical assistant concerning a 15 years old female who on 10-JUN-2009 was vaccinated intramuscular administration in arm with the first dose of GARDASIL (661952/1129X). Concomitant therapy included (VARIVAX) and unspecified hepatitis A virus vaccine. On 10-JUN-2009 the patient fainted and experiencing jerking movements after receiving her first dose of GARDASIL. The patient had sought unspecified medical attention. At the time of the report, the patient had recovered on 10-JUN-2009. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Drug exposure during pregnancy, Injection site pain, Loss of consciousness, Pregnancy test positive
Clinical narrative: Information has been received from an 18 year old female patient with a history of fainting but no drug reactions or allergies who on 08-JUN-2009 was vaccinated IM with the first 0.5ml dose of GARDASIL (lot# 659054/0315Y). There was no concomitant medication. The patient reported that "after received the first dose of GARDASIL she passed out and her left arm was sore where she received the injection". A nurse reported that after the patient received her first dose of GARDASIL vaccine the patient became faint. The office told the patient to lie down and raise her feet; she was also given oxygen, some fluid and crackers. Then the patient found out by doing a home pregnancy test that she was 5 weeks pregnant. Therapy with GARDASIL was discontinued on 08-JUN-2009. It was reported that the patient sought unspecified medical attention. The patient recovered after about an hour from "became faint and passed out" on 08-JUN-2009 and left the office. The patient's outcome was unknown for vaccine exposure during pregnancy and left arm sore where vaccinated. Additional information has been requested.